Viral vector manufacturing shortage
Address the gap by understanding available strategies and how to select the most cost-effective solution.
Preparing for the future of biomanufacturing
New market dynamics are reshaping how biologics are produced and sold. Here’s what six industry experts say about the way forward.
Determining the right type of capacity
A flexible strategy can help you produce smaller scale, more potent molecules while supporting manufacturing of multiple products.
Expert insights on outsourcing
Choose a CDMO wisely to accelerate your programs while managing risk.
Mapping roads to the future
Explore available options to select a path based on molecule and facility fit needs.
Doubling up for speed in biomanufacturing
Parallel operations afford the opportunity to develop a process in a parallel path using the resources of an external CDMO partner.
Manufacturing cell and gene therapies
Services and manufacturing solutions for scalable and efficient end-to-end production.
End to end bioprocessing
Meet changing market demands with flexible solutions to help manage process complexity.
Vector manufacturing
Rapidly add capacity and retain flexibility with modular end-to-end options.
Fast Trak Biomanufacturing Services
Biologics contract development and manufacturing organization (CDMO).
Case studies
From feasibility to biomanufacturing facility.